Literature DB >> 12560352

Influence of urinary stones on the composition of a 24-hour urine sample.

Norbert Laube1, Michael Pullmann, Stefan Hergarten, Albrecht Hesse.   

Abstract

BACKGROUND: It can be assumed that stones in the urinary tract continuously increase in size by incorporating material from urine. Consequently, urine will exhibit depleted concentrations of lithogenic constituents when urinary stones are present in the patient's urinary tract.
METHODS: To calculate the influence of the depletion effect, we considered two different models of stone growth. In the first model, the increase in stone size depends only on the urinary concentration of a lithogenic substance; the second model also considers the surface area of the growing stone. The case of only one kidney being affected by stone formation is considered separately. We discuss example calculations involving the formation of calcium oxalate.
RESULTS: The calculated depletion effects are of a nonnegligible order of magnitude. Assuming both a measured oxalate concentration of, e.g., 0.37 mmol/L and a reasonable in vivo stone growing rate of 10 mm(3)/day, a relative underestimation of the real "in situ" oxalate concentration between approximately 21% (model 1) and approximately 42% (model 2) occurs. The depletion effect increases markedly with increasing stone growth rate.
CONCLUSIONS: Metabolic status can be evaluated correctly only in patients who have been declared "stone-free", e.g., after stone removal. Because the expected stone-related depletion effect in most cases is of high clinical relevance, we recommend estimating the effect of the order of magnitude of the depletion on actual urinary composition.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12560352     DOI: 10.1373/49.2.281

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  9 in total

1.  A stone farm: development of a method for simultaneous production of multiple calcium oxalate stones in vitro.

Authors:  K Chow; J Dixon; S Gilpin; J P Kavanagh; P N Rao
Journal:  Urol Res       Date:  2003-10-22

2.  Problems in the investigation of urine from patients suffering from primary hyperoxaluria type 1.

Authors:  N Laube; B Hoppe; A Hesse
Journal:  Urol Res       Date:  2005-09-08

Review 3.  The use of risk indices: do they predict recurrence? Yes, they (at least some) do.

Authors:  Norbert Laube; Michael Pullmann
Journal:  Urol Res       Date:  2006-01-06

Review 4.  [Carefully conducted preanalytic and postanalytic procedures for urine samples. Often neglected in urolithiasis treatment].

Authors:  N Laube; W Berg
Journal:  Urologe A       Date:  2014-01       Impact factor: 0.639

5.  Kinetics of calcium oxalate crystal formation in urine.

Authors:  Norbert Laube; Florian Klein; Falk Bernsmann
Journal:  Urolithiasis       Date:  2016-06-21       Impact factor: 3.436

Review 6.  [S2k guidelines on diagnostics, therapy and metaphylaxis of urolithiasis (AWMF 043/025) : Compendium].

Authors:  T Knoll; T Bach; U Humke; A Neisius; R Stein; M Schönthaler; G Wendt-Nordahl
Journal:  Urologe A       Date:  2016-07       Impact factor: 0.639

7.  [Misdiagnosis of urinalysis due to in vivo formation of urinary stones].

Authors:  N Laube; M Pullmann; S Hergarten; M Schmidt; A Hesse
Journal:  Urologe A       Date:  2003-12       Impact factor: 0.639

8.  Difference in 24-Hour Urine Composition between Diabetic and Non-Diabetic Adults without Nephrolithiasis.

Authors:  Wei Zhu; Zanlin Mai; Jing Qin; Xiaolu Duan; Yang Liu; Zhijian Zhao; Jian Yuan; Shaw P Wan; Guohua Zeng
Journal:  PLoS One       Date:  2016-02-23       Impact factor: 3.240

9.  Correspondence between Ca²⁺ and calciuria, citrate level and pH of urine in pediatric urolithiasis.

Authors:  Tadeusz Porowski; Jan K Kirejczyk; Jerzy Konstantynowicz; Anna Kazberuk; Grzegorz Plonski; Anna Wasilewska; Norbert Laube
Journal:  Pediatr Nephrol       Date:  2013-02-03       Impact factor: 3.714

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.